PDCD1 and pancreatic neoplasm: In the pancreatic tumor microenvironment, CD8+ T cells were found to blockade PD-1 checkpoints and CXCR4 to exert an antitumor effect, suggested the promising objectives of immunotherapies (Seo et al., 2019).